杭州泰格医药科技股份有限公司于2026年8月3日发布2026年7月股份变动月报表。报告披露，截至2026年7月31日，公司法定/注册股本总额为人民币861,026,050元，与上月末保持不变。
在已发行股票方面，公司A股已发行股份数为711,053,992股，库存股为26,847,258股，总数为737,901,250股，较上月未发生变动；H股已发行股份数为123,124,800股，库存股为0股，总数为123,124,800股，同样保持稳定。报告期内无新增发行、回购或注销股份事项，也无股份期权或股权激励计划变动。公司此前于2024年至2026年期间基于多次回购累积获得26,847,258股A股库存股份，此次月度报告期间无新进展。
目前，公司已确认遵守香港联交所《上市规则》及相关法律法规对最低公众持股量的要求。该月报表由公司董事叶小平正式签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.